138 filings
Page 3 of 7
8-K
mqdpu9 vva51lp
6 Oct 22
Other Events
4:20pm
8-K
uuurcdg ol74
21 Sep 22
Other Events
9:05am
8-K
pwkz6 qyzzcvh
9 Aug 22
Allogene Therapeutics Reports Second Quarter 2022 Financial Results
12:00am
SC TO-I/A
fkh05agibqtrfeskg92a
20 Jul 22
Issuer tender offer statement (amended)
4:03pm
SC TO-I/A
eol2dxl 3yc
12 Jul 22
Issuer tender offer statement (amended)
4:09pm
8-K
y94545 v849uggs2y
12 Jul 22
Departure of Directors or Certain Officers
4:05pm
SC TO-I
bdiq v0ajs554j
21 Jun 22
Issuer tender offer statement
9:05am
8-K
9adsgqjk u8iqlol9eiw
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
yg3rck1jtr
4 May 22
Allogene Therapeutics Reports First Quarter 2022 Financial Results
4:09pm
DEFA14A
qdwj yfclso61
26 Apr 22
Additional proxy soliciting materials
4:35pm
SC TO-C
rnv8y7i2nck
14 Apr 22
Information about tender offer
4:40pm
PRE 14A
5ee0aab8
14 Apr 22
Preliminary proxy
4:10pm
S-8
grm5lu
23 Feb 22
Registration of securities for employees
4:20pm
8-K
416r522b99clpokalp
23 Feb 22
Allogene Therapeutics Reports Fourth Quarter and Full Year 2021
4:08pm
8-K
l37ag 2r61il1
15 Dec 21
Entry into a Material Definitive Agreement
10:09am